4.8 Article

Catalytic Synthesis of Amino Acid and Peptide Derivatized Gadonanotubes

期刊

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
卷 131, 期 24, 页码 8342-+

出版社

AMER CHEMICAL SOC
DOI: 10.1021/ja900918x

关键词

-

资金

  1. Robert A. Welch Foundation [C-0624]
  2. Nanoscale Science and Engineering Initiative of the National Science Foundation [EEC-0647452]
  3. Cancer Center [1 P30 CA 125123]
  4. Helis Medical Research Foundation
  5. NCI/NIH SPORE [P50CA58183]

向作者/读者索取更多资源

A new Rh-6(CO)(16)-catalyzed functionalization of gadonanotube MRI probes offers the opportunity to prepare a number of amino acid and peptide derivatized gadonanotubes under RT conditions, containing, for example, the cyclic RGD peptide for the biological targeting of cancer.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Nanoscience & Nanotechnology

Gold-Small Interfering RNA as Optically Responsive Nanostructures for Cancer Theranostics

Xi Yang, Bhanu Prasad Venkatesulu, Lakshmi Shree Mahadevan, Maureen L. Aliru, Yuri Mackeyev, Ajay Singh, Paras N. Prasad, Sunil Krishnan

JOURNAL OF BIOMEDICAL NANOTECHNOLOGY (2018)

Article Nanoscience & Nanotechnology

Boron-Nanoparticle-Loaded Folic-Acid-Functionalized Liposomes to Achieve Optimum Boron Concentration for Boron Neutron Capture Therapy of Cancer

Ajay Singh, Byung Kyu Kim, Yuri Mackeyev, Parham Rohani, Supriya D. Mahajan, Mark T. Swihart, Sunil Krishnan, Paras N. Prasad

JOURNAL OF BIOMEDICAL NANOTECHNOLOGY (2019)

Correction Biotechnology & Applied Microbiology

A recellularized human colon model identifies cancer driver genes (vol 34, pg 845, 2016)

Huanhuan Joyce Chen, Zhubo Wei, Jian Sun, Asmita Bhattacharya, David J. Savage, Rita Serda, Yuri Mackeyev, Steven A. Curley, Pengcheng Bu, Lihua Wang, Shuibing Chen, Leona Cohen-Gould, Emina Huang, Xiling Shen, Steven M. Lipkin, Neal G. Copeland, Nancy A. Jenkins, Michael L. Shuler

NATURE BIOTECHNOLOGY (2019)

Article Biology

Synthesis and characterization of gadolinium-decorated [60]fullerene for tumor imaging and radiation sensitization

Joseph Byung-Kyu Kim, Yuri Mackeyev, Subhiksha Raghuram, Sang Hyun Cho, Sunil Krishnan

Summary: The authors successfully developed a novel MRI contrast agent with higher relaxivity by coupling gadolinium ions to fullerene. However, this formulation did not result in the expected radiosensitization effect, suggesting the need for further exploration of alternative chemical modifications.

INTERNATIONAL JOURNAL OF RADIATION BIOLOGY (2021)

Article Oncology

Stability of MRI contrast agents in high-energy radiation of a 1.5T MR-Linac

Jihong Wang, Travis Salzillo, Yongying Jiang, Yuri Mackeyev, Clifton David Fuller, Caroline Chung, Seungtaek Choi, Neil Hughes, Yao Ding, Jinzhong Yang, Sastry Vedam, Sunil Krishnan

Summary: This study focused on analyzing the molecular stability of MRI contrast agents when exposed to high energy photons and secondary electrons in a 1.5T MR-Linac system. The results showed no significant changes in chemical composition or displacement of gadolinium ions from their chelates in samples irradiated with 7 MV photons at clinical doses. Additionally, there was no significant correlation observed between concentrations of irradiated MRI contrast agents and radiation dose.

RADIOTHERAPY AND ONCOLOGY (2021)

Article Biotechnology & Applied Microbiology

3JC48-3 (methyl 4′-methyl-5-(7-nitrobenzo[c][1,2,5]oxadiazol-4-yl)-[1,1′-biphenyl]-3-carboxylate): a novel MYC/MAX dimerization inhibitor reduces prostate cancer growth

Sanjeev Shukla, Steven Fletcher, Jay Chauhan, Victor Chalfant, Carlos Riveros, Yuri Mackeyev, Pankaj Kumar Singh, Sunil Krishnan, Teruko Osumi, K. C. Balaji

Summary: This study demonstrates that 3JC48-3 is a potent MYC/MAX heterodimerization inhibitor that decreases prostate cancer growth and viability associated with upregulation of PrKD1 expression and kinase activity.

CANCER GENE THERAPY (2022)

Article Oncology

Identification of Synergistic Drug Combinations to Target KRAS-Driven Chemoradioresistant Cancers Utilizing Tumoroid Models of Colorectal Adenocarcinoma and Recurrent Glioblastoma

Kshama Gupta, Jeremy C. Jones, Virginea De Araujo Farias, Yuri Mackeyev, Pankaj K. Singh, Alfredo Quinones-Hinojosa, Sunil Krishnan

Summary: Treatment resistance is common in advanced cancers, including colorectal adenocarcinoma (COAD). A study found that targeting the DDR1/BCR-ABL signaling axis with EGFR-ERBB2 could be a potential strategy for treating chemotherapy and radiotherapy-resistant COAD and glioblastoma (GBM) tumors driven by the KRAS mutation.

FRONTIERS IN ONCOLOGY (2022)

Article Engineering, Biomedical

Uncloaking cell-impermeant gold nanorods via tumor microenvironmental cathepsin B facilitates cancer cell penetration and potent radiosensitization

Subhiksha Raghuram, Yuri Mackeyev, Jessica Symons, Yasmin Zahra, Valeria Gonzalez, Krishnan K. Mahadevan, Katherinne I. Requejo, Anton Liopo, Paul Derry, Eugene Zubarev, Onur Sahin, Joseph Byung-Kyu Kim, Pankaj K. Singh, Sang Hyun Cho, Sunil Krishnan

Summary: This study describes a smart gold nanorod that can spontaneously transform into active nanoparticles within tumors, sensitizing tumors to radiation therapy. By cloaking the nanorod with a protective layer, it can be uncloaked by specific proteases in the tumor microenvironment, making it readily internalized by cancer cells. Selective uncloaking of the nanorod reduces off-target toxicity in normal tissues.

BIOMATERIALS (2022)

Article Multidisciplinary Sciences

Pancreatic tumor microenvironmental acidosis and hypoxia transform gold nanorods into cell-penetrant particles for potent radiosensitization

Pradipta Ranjan Rauta, Yuri Mackeyev, Keith Sanders, Joseph B. K. Kim, Valeria V. Gonzalez, Yasmin Zahra, Muhammad A. Shohayeb, Belal Abousaida, Geraldine V. Vijay, Okan Tezcan, Paul Derry, Anton V. Liopo, Eugene R. Zubarev, Rickey Carter, Pankaj Singh, Sunil Krishnan

Summary: This article investigates gold nanorods with a responsive epilayer that can transform into cell-penetrating particles in the acidic tumor microenvironment. The study finds that when administered intravenously in mice, these nanorods can accumulate in tumors without causing significant harm to animal health, and they can effectively enhance the efficacy of radiation therapy for tumors.

SCIENCE ADVANCES (2022)

Review Cell Biology

Next-Generation Boron Drugs and Rational Translational Studies Driving the Revival of BNCT

Danushka S. Seneviratne, Omran Saifi, Yuri Mackeyev, Timothy Malouff, Sunil Krishnan

Summary: BNCT is a high-linear-energy transfer therapy that selectively delivers radiation to tumor cells while sparing normal tissues. The focus is on developing boronated compounds with high selectivity, ease of delivery, and large boron payloads. There is also interest in exploring the immunogenic potential of BNCT and utilizing it to improve outcomes in difficult-to-treat malignancies. This review covers the radiobiological and physical aspects of BNCT, traditional and next-generation boron compounds, as well as translational studies and innovative approaches for leveraging BNCT's immunogenicity.
Review Oncology

Radiolabeled nanomaterial for cancer diagnostics and therapeutics: principles and concepts

Muskan Goel, Yuri Mackeyev, Sunil Krishnan

Summary: Radiopharmaceuticals have shown their effectiveness in cancer diagnosis and therapy over the past three decades. The advancements in nanotechnology have led to the development of nanotechnology-aided radiopharmaceuticals, which utilize the unique properties of nanoparticles to enhance imaging and therapy of human diseases.

CANCER NANOTECHNOLOGY (2023)

Article Oncology

Dual enhancement in the radiosensitivity of prostate cancer through nanoparticles and chemotherapeutics

Nolan Jackson, Iona Hill, Abdulaziz Alhussan, Kyle Bromma, Jessica Morgan, Belal Abousaida, Yasmin Zahra, Yuri Mackeyev, Wayne Beckham, Steven Herchko, Sunil Krishnan, Devika Basnagge Chithrani

Summary: Incorporating docetaxel with gold nanoparticles and radiotherapy can enhance the efficacy of radiotherapy treatment, potentially improving tumor control through local dose enhancement.

CANCER NANOTECHNOLOGY (2023)

Meeting Abstract Oncology

X-Ray Triggered Nanoscintillators Photosensitize Pancreatic Cancer and Stimulate a Robust Systemic Immune Response

O. Sahin, Y. Mackeyev, G. Vijay, S. Roy, V. Gonzalez, Y. Zahra, O. Tezcan, B. Abousaida, B. Venkatesulu, P. K. Singh, S. H. Cho, P. Ajayan, S. Krishnan

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2022)

Article Chemistry, Multidisciplinary

CXC chemokine receptor 4 (CXCR4) targeted gold nanoparticles potently enhance radiotherapy outcomes in breast cancer

Shanta Bhattarai, Yuri Mackeyev, Bhanu P. Venkatesulu, Sunil Krishnan, Pankaj K. Singh

Summary: CXCR4-targeted gold nanoparticles show enhanced radiosensitization of breast cancer cells with CXCR4 overexpression, leading to increased cellular internalization, unrepaired DNA double strand breaks, and production of oxygen free radicals. In a murine TNBC xenograft model, CXCR4 targeting significantly increases tumor regrowth delay following radiation compared to radiation with non-targeted GNPs or vehicle alone, suggesting that CXCR4-targeted GNPs can enhance the efficacy of TNBC radiotherapy through increasing oxidative stress and DNA damage.

NANOSCALE (2021)

Article Engineering, Biomedical

The influence of cell and nanoparticle properties on heating and cell death in a radiofrequency field

Yuri Mackeyev, Colette Mark, Natasha Kumar, Rita E. Serda

ACTA BIOMATERIALIA (2017)

暂无数据